EZR and breast carcinoma: We showed here that in breast cancer cells, Syk phosphorylates ezrin on the Tyr424 residue, rather than Tyr353 as it occurs in B lymphocytes, and could induce a signaling cascade different than the ones previously described for tyrosine phosphorylated ezrin.